TY - JOUR AU - Wingard, D. L. AU - Barrett-Connor, E. L. AU - Ferrara, A. PY - 1995 DA - 1995// TI - Is insulin really a heart disease risk factor JO - Diabetes Care VL - 18 UR - https://doi.org/10.2337/diacare.18.9.1299 DO - 10.2337/diacare.18.9.1299 ID - Wingard1995 ER - TY - JOUR AU - Kannel, W. B. AU - D'Agostino, R. B. AU - Wilson, P. W. AU - Belanger, A. J. AU - Gagnon, D. R. PY - 1990 DA - 1990// TI - Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience JO - Am Heart J VL - 120 UR - https://doi.org/10.1016/0002-8703(90)90026-T DO - 10.1016/0002-8703(90)90026-T ID - Kannel1990 ER - TY - JOUR AU - Stamler, J. AU - Vaccaro, O. AU - Neaton, J. D. AU - Wentworth, D. PY - 1993 DA - 1993// TI - Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial JO - Diabetes Care VL - 16 UR - https://doi.org/10.2337/diacare.16.2.434 DO - 10.2337/diacare.16.2.434 ID - Stamler1993 ER - TY - JOUR PY - 1998 DA - 1998// TI - Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 JO - BMJ VL - 317 UR - https://doi.org/10.1136/bmj.317.7160.703 DO - 10.1136/bmj.317.7160.703 ID - ref4 ER - TY - JOUR AU - Chobanian, A. V. AU - Bakris, G. L. AU - Black, H. R. AU - Cushman, W. C. AU - Green, L. A. AU - Izzo, J. L. AU - Jones, D. W. AU - Materson, B. J. AU - Oparil, S. AU - Wright, J. T. AU - Roccella, E. J. PY - 2003 DA - 2003// TI - The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JO - JAMA VL - 289 UR - https://doi.org/10.1001/jama.289.19.2560 DO - 10.1001/jama.289.19.2560 ID - Chobanian2003 ER - TY - CHAP PY - 2005 DA - 2005// BT - Global Guideline for Type 2 Diabetes PB - International Diabetes Federation CY - Brussels ID - ref6 ER - TY - JOUR PY - 2003 DA - 2003// TI - 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension JO - J Hypertens VL - 21 UR - https://doi.org/10.1097/00004872-200306000-00001 DO - 10.1097/00004872-200306000-00001 ID - ref7 ER - TY - JOUR AU - Brenner, B. M. AU - Cooper, M. E. AU - De Zeeuw, D. AU - Keane, W. F. AU - Mitch, W. E. AU - Parving, H. H. AU - Remuzzi, G. AU - Snapinn, S. AU - Zhang, Z. AU - Shahinar, S. PY - 2001 DA - 2001// TI - Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa011161 DO - 10.1056/NEJMoa011161 ID - Brenner2001 ER - TY - JOUR AU - Lewis, E. J. AU - Hunsicker, L. G. AU - Clarke, W. R. AU - Berl, T. AU - Pohlmann, J. AU - Arjomand, H. AU - Rohde, R. AU - Raz, I. PY - 2001 DA - 2001// TI - Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa011303 DO - 10.1056/NEJMoa011303 ID - Lewis2001 ER - TY - JOUR PY - 1998 DA - 1998// TI - Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 JO - BMJ VL - 317 UR - https://doi.org/10.1136/bmj.317.7160.720 DO - 10.1136/bmj.317.7160.720 ID - ref10 ER - TY - JOUR AU - De Backer, G. AU - Ambrosioni, E. AU - Borch-Johnsen, K. AU - Brotons, C. AU - Cifkova, R. AU - Dallongeville, J. AU - Ebrahim, S. AU - Faergeman, O. AU - Graham, I. AU - Mancia, G. AU - Manger, C. AU - Orth-Gomer, K. AU - Perk, J. AU - Pyorala, K. AU - Rodicio, J. L. AU - Sans, S. AU - Sansoy, V. AU - Sechtem, U. AU - Silber, S. AU - Thomsen, T. AU - Wood, D. PY - 2003 DA - 2003// TI - European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice JO - Eur Heart J VL - 24 UR - https://doi.org/10.1016/S0195-668X(03)00347-6 DO - 10.1016/S0195-668X(03)00347-6 ID - De Backer2003 ER - TY - JOUR AU - Miyazaki, Y. AU - Glass, L. AU - Triplitt, C. AU - Matsuda, M. AU - Cusi, K. AU - Mahankali, A. AU - Mahankali, S. AU - Mandarino, L. J. AU - DeFronzo, R. A. PY - 2001 DA - 2001// TI - Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients JO - Diabetologia VL - 44 UR - https://doi.org/10.1007/s001250100031 DO - 10.1007/s001250100031 ID - Miyazaki2001 ER - TY - JOUR AU - Carey, D. G. AU - Cowin, G. J. AU - Galloway, G. J. AU - Jones, N. P. AU - Richards, J. C. AU - Biswas, N. AU - Doddrell, D. M. PY - 2002 DA - 2002// TI - Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected] JO - Obes Res VL - 10 UR - https://doi.org/10.1038/oby.2002.137 DO - 10.1038/oby.2002.137 ID - Carey2002 ER - TY - JOUR AU - Virtanen, K. A. AU - Hällsten, K. AU - Parkkola, R. AU - Janatuinen, T. AU - Lonnqvist, F. AU - Viljanen, T. AU - Ronnemaa, T. AU - Nuutila, P. PY - 2003 DA - 2003// TI - Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects JO - Diabetes VL - 52 UR - https://doi.org/10.2337/diabetes.52.2.283 DO - 10.2337/diabetes.52.2.283 ID - Virtanen2003 ER - TY - JOUR AU - Goldberg, R. B. AU - Kendall, D. M. AU - Deeg, M. A. AU - Buse, J. B. AU - Zagar, A. J. AU - Pinaire, J. A. AU - Tan, M. H. AU - Khan, M. A. AU - Perez, A. T. AU - Jacober, S. J. PY - 2005 DA - 2005// TI - A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia JO - Diabetes Care VL - 28 UR - https://doi.org/10.2337/diacare.28.7.1547 DO - 10.2337/diacare.28.7.1547 ID - Goldberg2005 ER - TY - JOUR AU - Haffner, S. AU - Greenberg, A. S. AU - Weston, W. M. AU - Chen, H. AU - Williams, K. AU - Freed, M. I. PY - 2002 DA - 2002// TI - Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus JO - Circulation VL - 106 UR - https://doi.org/10.1161/01.CIR.0000025403.20953.23 DO - 10.1161/01.CIR.0000025403.20953.23 ID - Haffner2002 ER - TY - JOUR AU - Stocker, D. J. AU - Taylor, A. J. AU - Langley, R. W. AU - Jezior, M. R. AU - Vigersky, R. A. PY - 2007 DA - 2007// TI - A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes JO - Am Heart J VL - 153 UR - https://doi.org/10.1016/j.ahj.2006.11.005 DO - 10.1016/j.ahj.2006.11.005 ID - Stocker2007 ER - TY - JOUR AU - Mazzone, T. AU - Meyer, P. M. AU - Feinstein, S. B. AU - Davidson, M. H. AU - Kondos, G. T. AU - D'Agostino, R. B. AU - Perez, A. AU - Provost, J. C. AU - Haffner, S. M. PY - 2006 DA - 2006// TI - Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial JO - JAMA VL - 296 UR - https://doi.org/10.1001/jama.296.21.joc60158 DO - 10.1001/jama.296.21.joc60158 ID - Mazzone2006 ER - TY - JOUR AU - Walker, A. B. AU - Chattington, P. D. AU - Buckingham, R. E. AU - Williams, G. PY - 1999 DA - 1999// TI - The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats JO - Diabetes VL - 48 UR - https://doi.org/10.2337/diabetes.48.7.1448 DO - 10.2337/diabetes.48.7.1448 ID - Walker1999 ER - TY - JOUR AU - Bennett, S. M. AU - Agrawal, A. AU - Elasha, H. AU - Heise, M. AU - Jones, N. P. AU - Walker, M. AU - Wilding, J. P. PY - 2004 DA - 2004// TI - Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance JO - Diabet Med VL - 21 UR - https://doi.org/10.1111/j.1464-5491.2004.01155.x DO - 10.1111/j.1464-5491.2004.01155.x ID - Bennett2004 ER - TY - JOUR AU - Negro, R. AU - Mangieri, T. AU - Dazzi, D. AU - Pezzarossa, A. AU - Hassan, H. PY - 2005 DA - 2005// TI - Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients JO - Diabetes Res Clin Pract VL - 70 UR - https://doi.org/10.1016/j.diabres.2005.02.012 DO - 10.1016/j.diabres.2005.02.012 ID - Negro2005 ER - TY - JOUR AU - St John Sutton, M. AU - Rendell, M. AU - Dandona, P. AU - Dole, J. F. AU - Murphy, K. AU - Patwardhan, R. AU - Patel, J. AU - Freed, M. PY - 2002 DA - 2002// TI - A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes mellitus JO - Diabetes Care VL - 25 UR - https://doi.org/10.2337/diacare.25.11.2058 DO - 10.2337/diacare.25.11.2058 ID - St John Sutton2002 ER - TY - JOUR AU - Natali, A. AU - Baldeweg, S. AU - Toschi, E. AU - Capaldo, B. AU - Barbaro, D. AU - Gastaldelli, A. AU - Yudkin, J. S. AU - Ferrannini, E. PY - 2004 DA - 2004// TI - Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes JO - Diabetes Care VL - 27 UR - https://doi.org/10.2337/diacare.27.6.1349 DO - 10.2337/diacare.27.6.1349 ID - Natali2004 ER - TY - JOUR AU - Honisett, S. Y. AU - Stojanovska, L. AU - Sudhir, K. AU - Kingwell, B. A. AU - Dawood, T. AU - Komesaroff, P. A. PY - 2003 DA - 2003// TI - Rosiglitazone lowers blood pressure and increases arterial compliance in postmenopausal women with type 2 diabetes JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.11.3194 DO - 10.2337/diacare.26.11.3194 ID - Honisett2003 ER - TY - JOUR AU - Calvo, C. AU - Lopez, J. E. AU - Covelo, M. AU - Dominguez, M. J. AU - Martinez, C. AU - Lorenzo, V. AU - Ayala, D. E. AU - Hermida, R. C. PY - 2002 DA - 2002// TI - Diabetes and arteriosclerosis. The role of antagonists of PPAR-gamma JO - Am J Hypertens VL - 15 (Suppl 1) UR - https://doi.org/10.1016/S0895-7061(02)02783-8 DO - 10.1016/S0895-7061(02)02783-8 ID - Calvo2002 ER - TY - JOUR AU - Sarafidis, P. A. AU - Lasaridis, A. N. AU - Nilsson, P. M. AU - Pagkalos, E. M. AU - Hitoglou-Makedou, A. D. AU - Pliakos, C. I. AU - Kazakos, K. A. AU - Yovos, J. G. AU - Zebekakis, P. E. AU - Tziolas, I. M. AU - Tourkantonis, A. N. PY - 2004 DA - 2004// TI - Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase JO - J Hypertens VL - 22 UR - https://doi.org/10.1097/00004872-200409000-00022 DO - 10.1097/00004872-200409000-00022 ID - Sarafidis2004 ER - TY - JOUR AU - Yosefy, C. AU - Magen, E. AU - Kiselevich, A. AU - Priluk, R. AU - London, D. AU - Volchek, L. AU - Viskoper, R. J. PY - 2004 DA - 2004// TI - Rosiglitazone improves, while glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity JO - J Cardiovasc Pharmacol VL - 44 UR - https://doi.org/10.1097/00005344-200408000-00011 DO - 10.1097/00005344-200408000-00011 ID - Yosefy2004 ER - TY - JOUR AU - Raji, A. AU - Seely, E. W. AU - Bekins, S. A. AU - Williams, G. H. AU - Simonson, D. C. PY - 2003 DA - 2003// TI - Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.1.172 DO - 10.2337/diacare.26.1.172 ID - Raji2003 ER - TY - JOUR AU - Home, P. D. AU - Pocock, S. J. AU - Beck-Nielsen, H. AU - Gomis, R. AU - Hanefeld, M. AU - Dargie, H. AU - Komajda, M. AU - Gubb, J. AU - Biswas, N. AU - Jones, N. P. PY - 2005 DA - 2005// TI - Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol JO - Diabetologia VL - 48 UR - https://doi.org/10.1007/s00125-005-1869-1 DO - 10.1007/s00125-005-1869-1 ID - Home2005 ER - TY - CHAP PY - 1999 DA - 1999// BT - Definition, diagnosis and classification of diabetes mellitus and its complications. Document WHO/NCD/NCS/99.2 PB - Geneva CY - WHO Department of Noncommunicable Disease Surveillance ID - ref30 ER - TY - JOUR PY - 1999 DA - 1999// TI - A desktop guide to type 2 diabetes JO - Diabet Med VL - 16 UR - https://doi.org/10.1046/j.1464-5491.1999.00166.x DO - 10.1046/j.1464-5491.1999.00166.x ID - ref31 ER - TY - JOUR AU - O'Brien, E. AU - Atkins, N. AU - Staessen, J. PY - 1995 DA - 1995// TI - State of the market. A review of ambulatory blood pressure monitoring devices JO - Hypertension VL - 26 UR - https://doi.org/10.1161/01.HYP.26.5.835 DO - 10.1161/01.HYP.26.5.835 ID - O'Brien1995 ER - TY - CHAP PY - 2005 DA - 2005// BT - HOMA calculator ID - ref33 ER - TY - JOUR AU - Nissen, S. E. AU - Wolski, K. PY - 2007 DA - 2007// TI - Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa072761 DO - 10.1056/NEJMoa072761 ID - Nissen2007 ER - TY - JOUR AU - Home, P. D. AU - Pocock, S. J. AU - Beck-Nielsen, H. AU - Gomis, R. AU - Hanefeld, M. AU - Jones, N. P. AU - Komajda, M. AU - McMurray, J. J. V. PY - 2007 DA - 2007// TI - Rosiglitazone evaluated for cardiovascular outcomes - an interim analysis JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa073394 DO - 10.1056/NEJMoa073394 ID - Home2007 ER - TY - CHAP PY - 2007 DA - 2007// BT - Advisory Committee Briefing Document. Cardiovascular Safety of Rosiglitazone. Endocrinologic and Metabolic Drugs Advisory Committee Drug Safety and Risk Management Advisory Committee Meeting on July 30 ID - ref36 ER - TY - JOUR AU - Dormandy, J. A. AU - Charbonnel, B. AU - Eckland, D. A. AU - Erdmann, E. AU - Massi-Benedetti, M. AU - Moules, I. AU - Skene, A. AU - Tan, M. H. AU - Lefebvre, P. J. AU - Murray, G. D. AU - Standl, E. AU - Wilcox, R. G. AU - Wilhelmsen, L. AU - Betteridge, D. J. AU - Birkeland, K. I. AU - Golay, A. AU - RJ, H. AU - Koranyi, L. AU - Laakso, M. AU - Mokan, M. AU - Norkus, A. AU - Pirags, V. AU - Podar, T. AU - Scheen, A. AU - Scherbaum, W. AU - Schernthaner, G. AU - Schmitz, O. AU - Skrha, J. AU - Smith, U. AU - Taton, J. PY - 2005 DA - 2005// TI - Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67528-9 DO - 10.1016/S0140-6736(05)67528-9 ID - Dormandy2005 ER - TY - JOUR AU - Pfutzner, A. AU - Marx, N. AU - Lübben, G. AU - Langenfeld, M. AU - Walcher, D. AU - Konrad, T. AU - Forst, T. PY - 2005 DA - 2005// TI - Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the Pioneer study JO - J Am Coll Cardiol VL - 45 UR - https://doi.org/10.1016/j.jacc.2005.03.041 DO - 10.1016/j.jacc.2005.03.041 ID - Pfutzner2005 ER - TY - JOUR AU - Pistrosch, F. AU - Passauer, J. AU - Fischer, S. AU - Fuecker, K. AU - Hanefeld, M. AU - Gross, P. PY - 2004 DA - 2004// TI - In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control JO - Diabetes Care VL - 27 UR - https://doi.org/10.2337/diacare.27.2.484 DO - 10.2337/diacare.27.2.484 ID - Pistrosch2004 ER - TY - JOUR AU - Stuhlinger, M. C. AU - Abbasi, F. AU - Chu, J. W. AU - Lamendola, C. AU - McLaughlin, T. L. AU - Cooke, J. P. AU - Reaven, G. M. AU - Tsao, P. S. PY - 2002 DA - 2002// TI - Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor JO - JAMA VL - 287 UR - https://doi.org/10.1001/jama.287.11.1420 DO - 10.1001/jama.287.11.1420 ID - Stuhlinger2002 ER - TY - JOUR AU - Shargorodsky, M. AU - Wainstein, G. AU - Gavish, E. AU - Leibovitz, Z. AU - Matas, D. AU - Zimlichman, R. PY - 2003 DA - 2003// TI - Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus JO - Am J Hypertens VL - 16 UR - https://doi.org/10.1016/S0895-7061(03)00911-7 DO - 10.1016/S0895-7061(03)00911-7 ID - Shargorodsky2003 ER - TY - JOUR AU - Buchanan, T. A. AU - Meehan, W. P. AU - Jeng, Y. Y. AU - Yang, D. AU - Chan, T. M. AU - Nadler, J. L. AU - Scott, S. AU - Rude, R. K. AU - Hsueh, W. A. PY - 1995 DA - 1995// TI - Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect JO - J Clin Invest VL - 96 UR - https://doi.org/10.1172/JCI118041 DO - 10.1172/JCI118041 ID - Buchanan1995 ER - TY - JOUR AU - Song, J. AU - Walsh, M. F. AU - Igwe, R. AU - Ram, J. L. AU - Barazi, M. AU - Dominguez, L. J. AU - Sowers, J. R. PY - 1997 DA - 1997// TI - Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production JO - Diabetes VL - 46 UR - https://doi.org/10.2337/diab.46.4.659 DO - 10.2337/diab.46.4.659 ID - Song1997 ER - TY - JOUR AU - Zhang, F. AU - Sowers, J. R. AU - Ram, J. L. AU - Standley, P. R. AU - Peuler, J. D. PY - 1994 DA - 1994// TI - Effects of pioglitazone on calcium channels in vascular smooth muscle JO - Hypertension VL - 24 UR - https://doi.org/10.1161/01.HYP.24.2.170 DO - 10.1161/01.HYP.24.2.170 ID - Zhang1994 ER - TY - JOUR AU - Brayden, J. E. AU - Nelson, M. T. PY - 1992 DA - 1992// TI - Regulation of arterial tone by activation of calcium-dependent potassium channels JO - Science VL - 256 UR - https://doi.org/10.1126/science.1373909 DO - 10.1126/science.1373909 ID - Brayden1992 ER - TY - JOUR AU - Hernandez-Trujillo, Y. AU - Rodriguez-Esparragon, F. AU - Macias-Reyes, A. AU - Caballero-Hidalgo, A. AU - Rodriguez-Perez, J. C. PY - 2008 DA - 2008// TI - Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model JO - Cardiovasc Diabetol VL - 7 UR - https://doi.org/10.1186/1475-2840-7-3 DO - 10.1186/1475-2840-7-3 ID - Hernandez-Trujillo2008 ER - TY - JOUR AU - Harte, A. AU - McTernan, P. AU - Chetty, R. AU - Coppack, S. AU - Katz, J. AU - Smith, S. AU - Kumar, S. PY - 2005 DA - 2005// TI - Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone JO - Circulation VL - 111 UR - https://doi.org/10.1161/01.CIR.0000161954.17870.5D DO - 10.1161/01.CIR.0000161954.17870.5D ID - Harte2005 ER - TY - JOUR AU - Adler, A. I. AU - Stratton, I. M. AU - Neil, H. A. AU - Yudkin, J. S. AU - Matthews, D. R. AU - Cull, C. A. AU - Wright, A. D. AU - Turner, R. C. AU - Holman, R. R. PY - 2000 DA - 2000// TI - Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study JO - BMJ VL - 321 UR - https://doi.org/10.1136/bmj.321.7258.412 DO - 10.1136/bmj.321.7258.412 ID - Adler2000 ER - TY - JOUR AU - Yusuf, S. AU - Sleight, P. AU - Pogue, J. AU - Bosch, J. AU - Davies, R. AU - Dagenais, G. PY - 2000 DA - 2000// TI - Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators JO - N Engl J Med VL - 342 UR - https://doi.org/10.1056/NEJM200001203420301 DO - 10.1056/NEJM200001203420301 ID - Yusuf2000 ER - TY - JOUR AU - Hansson, L. AU - Zanchetti, A. AU - Carruthers, S. G. AU - Dahlof, B. AU - Elmfeldt, D. AU - Julius, S. AU - Menard, J. AU - Rahn, K. H. AU - Wedel, H. AU - Westerling, S. PY - 1998 DA - 1998// TI - Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group JO - Lancet VL - 351 UR - https://doi.org/10.1016/S0140-6736(98)04311-6 DO - 10.1016/S0140-6736(98)04311-6 ID - Hansson1998 ER - TY - JOUR AU - Erdmann, E. AU - Dormandy, J. A. AU - Charbonnel, B. AU - Massi-Benedetti, M. AU - Moules, I. K. AU - Skene, A. M. PY - 2007 DA - 2007// TI - The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study JO - J Am Coll Cardiol VL - 49 UR - https://doi.org/10.1016/j.jacc.2006.12.048 DO - 10.1016/j.jacc.2006.12.048 ID - Erdmann2007 ER - TY - JOUR AU - McAfee, A. T. AU - Koro, C. AU - Landon, J. AU - Ziyadeh, N. AU - Walker, A. M. PY - 2007 DA - 2007// TI - Coronary heart disease outcomes in patients receiving antidiabetic agents JO - Pharmacoepidemiol Drug Saf VL - 16 UR - https://doi.org/10.1002/pds.1443 DO - 10.1002/pds.1443 ID - McAfee2007 ER - TY - JOUR AU - Lipscombe, L. L. AU - Gomes, T. AU - Levesque, L. E. AU - Hux, J. E. AU - Juurlink, D. N. AU - Alter, D. A. PY - 2007 DA - 2007// TI - Thiazolidinediones and cardiovascular outcomes in older patients with diabetes JO - JAMA VL - 298 UR - https://doi.org/10.1001/jama.298.22.2634 DO - 10.1001/jama.298.22.2634 ID - Lipscombe2007 ER -